ROCHE PRODUCTS PTY LTD

ABN: 70000132865Sydney, NSW
Enterprise ($50M+)
$670.9M
Total Value
2
Total Contracts
Drugs and Pharmaceutical
Primary Category

Recent Contracts

Active
Drugs and Pharmaceutical
18 July 2025
CN4171505—Procurement of Imported Plasma and Recombinant Products (IPRP) – Hemlibra (emicizumab)$317.7M

30 June 2025 - 29 June 2028

National Blood Authority
Expired
Drugs and Pharmaceutical
4 Nov 2020
CN3727716—Supply of Hemlibra$353.2M

31 Oct 2020 - 29 June 2025

National Blood Authority

Retender Opportunities

10 expiring contracts in this supplier's categories that may be retendered soon.

Unlock 10 retender opportunities

See contract values, current suppliers, and exact expiry dates.

Peer Benchmarking

See how ROCHE PRODUCTS PTY LTD ranks against similar companies in their category and size band.

Financial Year Breakdown

FY25
$317.7M(1 contracts)
FY21
$353.2M(1 contracts)

Company Details

Name
ROCHE PRODUCTS PTY LTD
Also known as
Roche Foundation Medicine
Entity Type
Australian Private Company
ABN
70 000 132 865
ACN
000 132 865
Status
Registered
Registered
3 June 1954
Town/City
Sydney
Postcode
2000
State/Territory
NSW
Country
Australia

Similar Suppliers

GLAXOSMITHKLINE AUSTRALIA PTY LTD$1.6BPFIZER AUSTRALIA PTY LTD$760.9MSEQIRUS (AUSTRALIA) PTY LTD$1.8BSANOFI-AVENTIS AUSTRALIA PTY LTD$528.8MCSL BEHRING (AUSTRALIA) PTY LTD$2.2B